Trial intelligence / Profile preview

Oxytocin effect on attentional processing of emotional faces

NCT04413786Completed

Sponsor
University of Electronic Science and Technology of China
Start
Oct 2019
Primary completion
Dec 2021
Countries
1
01

Overview

Randomised, double-blind trial of oxytocin nasal spray in Autism Spectrum Disorder (ASD) and Social Anxiety Disorder (SAD) (2 arms), sponsored by University of Electronic Science and Technology of China. Primary endpoints: Response time in response to different emotional face targets at 1 hour and N2pc ERP component at 1 hour. Started Oct 2019; status: completed.

02

Drugs

oxytocin nasal spray
03

Conditions

Autism Spectrum Disorder (ASD)Social Anxiety Disorder (SAD)

Beyond the preview

Go deeper on NCT04413786.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04413786.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call